welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
-
Endomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal CancerThe principle objective of this study is...
-
Video Capsule Endoscopy in Familial Adenomatous Polyposis: Capsule Entrapment in an Anal StenosisA 44-year-old woman with familial adenom...
-
Diagnostic Values of Dual Focus Narrow Band Imaging and Probe-Based Confocal Laser Endomicroscopy in FAP-Related Duo...BACKGROUND AND STUDY AIMS : Familial ade...
-
Hereditary Colorectal Cancer Syndromes and Genetic TestingColorectal cancer (CRC) is a leading cau...
-
Perinatal Detection of Familial Adenomatous PolyposisBACKGROUND : Hepatoblastoma is an uncomm...
-
Best Practice Guidelines for Molecular Analysis of Colorectal Polyposis: Familial Adenomatous Polyposis Coli (FAP) a...Background:. UK Clinical Molecular Genet...